159 filings
8-K
DMAC
DiaMedica Therapeutics Inc
10 Apr 24
Departure of Directors or Certain Officers
4:36pm
EFFECT
DMAC
DiaMedica Therapeutics Inc
10 Apr 24
Notice of effectiveness
12:15am
ARS
2023 FY
DMAC
DiaMedica Therapeutics Inc
4 Apr 24
Annual report to shareholders
6:12am
DEFA14A
DMAC
DiaMedica Therapeutics Inc
4 Apr 24
Additional proxy soliciting materials
6:06am
DEF 14A
DMAC
DiaMedica Therapeutics Inc
Definitive proxy
4 Apr 24
6:05am
8-K
xi9gw1l
19 Mar 24
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2023 Financial Results
4:16pm
8-K
k4ffs
13 Nov 23
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
4:52pm
8-K
pl8 dasj0iz4
5 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
3fytcxbk
14 Aug 23
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2023 Financial Results
4:25pm
424B3
v18qusqmj
10 Jul 23
Prospectus supplement
4:16pm
EFFECT
6s4bpp6qdvdr7rmn0o
10 Jul 23
Notice of effectiveness
12:15am
UPLOAD
szzv0ncutf8a zxl
5 Jul 23
Letter from SEC
12:00am
CORRESP
pgy284ue ijq4
5 Jul 23
Correspondence with SEC
12:00am
D
tpgct9nbd
27 Jun 23
$37.54 mm in equity, sold $37.54 mm, 34 investors
4:11pm
8-K
orqs1baxws
21 Jun 23
DiaMedica Therapeutics Announces $37.5 Million Private Placement
8:42am